The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Sensitivity to change and minimal clinically important difference of the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7)
Abstract
Background Effective treatment requires regular follow-up and monitoring of symptoms. We investigated sensitivity to change and minimal clinically important difference of the Generalized Anxiety Disorder Scale (GAD-7).Methods This study included all participants from a multisite trial of chronic depression. Baseline and follow-up (12 and 48 weeks) data were used to assess treatment response. Effect sizes (ES) and standardized response means (SRM) of pre- and post-GAD-7 mean changes were calculated for subgroups of patients, who did or did not improve according to ratings in the Hamilton Rating Scale for Depression (HRSD-24).Results N = 261 patients were included in the analyses. In the subgroup of patients who improved according to HRSD-24, GAD-7 scores were significantly lower after 12 weeks (t = -6.31, df = 120, p < .001; ES = -0.51, SRM = -0.57), and 48 weeks of treatment (t = -12.68, df = 141, p < .001; ES = -1.0, SRM = -1.7), when compared to admission. In the group who worsened, GAD-7 scores were significantly higher after 12 weeks (t = 2.96, df = 41, p = .005; ES = 0.30, SRM = 0.46), and increased after 48 weeks (t = 1.99, df = 21, p = .059; ES = 0.37, SRM = 0.43), when compared to baseline. The unchanged group showed no significant difference between baseline and follow-up. MCID was estimated 4 points on the GAD-7 total score.Limitations Confirmation of these findings and further investigation of the GAD-7 in populations and trials focusing on anxiety-specific treatment is highly recommended.Conclusions Results show that the GAD-7 is sensitive to detect change in psychopathology over the course of treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The minimal clinically important difference for GAD-7 was 3.8; the clinically relevant change was ≥4 points [51].”
From Clinical Efficacy and Psychological Mechanisms of an App-Based Digital Therapeutic for Generalized Anxiety Disorder: Randomized Controlled Trial (2021) · cites this paper as [51]
In the citing paper
“This change met the level of minimal clinical important difference (MCID), which is estimated at 4 points on the GAD-7 total score [30].”
From The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review (2022) · cites this paper as [30]
In the citing paper
“which is estimated at 4 points on the GAD-7 total score [30].”
From The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review (2022) · cites this paper as [30]
In the citing paper
“Anxiety will be measured with the 7-item Generalized Anxiety Disorder Scale (GAD-7; range, 0–21; higher scores indicate greater severity) [25].”
In the citing paper
“As noted above, we observed clinically meaningful improvements in both anxiety and depression, with reductions in GAD-7 (− 5.04) and PHQ-9 (− 5.64) higher than the MCID for both conditions (3.8 and 5, respectively) [66, 67].”
From Telerehabilitation of acute musculoskeletal multi-disorders: prospective, single-arm, interventional study (2022) · cites this paper as [66]
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
Self-citationKessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Diagnostic and Statistical Manual of Mental Disorders(DSM)
Leong, F. T. L. (2008) · Sage eBooks · doi:10.4135/9781412963978.n182 · Cited by 10,861
Lakens, D. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00863 · Cited by 10,303
Spitzer, R. L. (1999) · JAMA · doi:10.1001/jama.282.18.1737 · Cited by 9,802
Development of a Rating Scale for Primary Depressive Illness
Hamilton, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection
Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00004 · Cited by 4,741
Self-citation
Research works printed but not linked: 2
- First, 2002, Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition (SCID-I/P)
- Schuck, 2000, Z. Med. Psychol, 9, 125
Cited by
Sorted by citations
Items 101–200 of 638
Murkar, A., Kendzerska, T., Shlik, J., Quilty, L. C., Saad, M., & Robillard, R. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04185-7 · Cited by 18
“The proportion of individuals whose perceived symptom worsening was above the threshold for MCID was compared across the cannabis groups using chi-squared tests which were subsequently broken down using Bonferroni-corrected z-tests according to the procedure described by Sharpe [63].”
MethodInfluentialShan, D., Liu, C., Li, S., & Zheng, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.977361 · Cited by 16
Robison, R., Brendle, M., Moore, C., Cross, H. L., Helm, L., Darling, S., Thayer, S. D., Thielking, P., & Shannon, S. M. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2186285 · Cited by 17
Li, C., Liang, X., Cheng, S., Wen, Y. F., Pan, C., Zhang, H., Chen, Y., Zhang, Z., Zhang, Z., Yang, X., et al. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.01.009 · Cited by 15
Zhang, L., Zhao, S., Yang, Z., Hua, Z. X., & Lei, M. (2024) · Psychology Research and Behavior Management · doi:10.2147/prbm.s448698 · Cited by 15
Tsirmpas, C., Andrikopoulos, D., Fatouros, P., Eleftheriou, G., Anguera, J. A., Kontoangelos, K. A., & Papageorgiou, C. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.868970 · Cited by 14
“Minimal clinically important differences (MCID) are defined as at least five points for the PHQ-9 scores (62) and at least four points for the GAD-7 scores (63).”
BackgroundHoffart, A., Bauer, D. J., Johnson, S. U., & Ebrahimi, O. V. (2022) · Scientific Reports · doi:10.1038/s41598-022-22686-z · Cited by 12
Ando, M., Kao, Y., Lee, Y., Tai, S.-A., Mendez, S. R., Sasaki, K., Tang, W., & Papatheodorou, S. (2023) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x231151788 · Cited by 15
“32,36,37 It has seven questions on a four-point Likert Scale, producing a summed score ranging from 0 to 21.”
Changes in anxiety in the general population over a six-year period
Hinz, A., Esser, P., Friedrich, M., Glaesmer, H., Mehnert, A., Schroeter, M. L., Petrowski, K., & Toussaint, A. C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291206 · Cited by 14
Self-citationBetz, L. T., Jacob, G. A., Knitza, J., Köhm, M., & Behrens, F. (2024) · npj Mental Health Research · doi:10.1038/s44184-024-00085-8 · Cited by 17
Pierret, A. C. S., Benton, M., Gupta, P. S., & Ismail, K. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02392-0 · Cited by 19
Item Response Theory Analysis: PROMIS® Anxiety Form and Generalized Anxiety Disorder Scale
Liu, W., Dindo, L. N., Hadlandsmyth, K., Unick, G. J., Zimmerman, M. B., Marie, B. S., Embree, J. L., Tripp‐Reimer, T., & Rakel, B. A. (2021) · Western Journal of Nursing Research · doi:10.1177/01939459211015985 · Cited by 14
“…in different adult patient populations using CTT, including patients following coronary artery bypass surgery (Tully & Baker, 2012), orthopedic surgery (Hadlandsmyth et al., 2020), and patients with chronic depression (Toussaint et al., 2020), anxiety, and mood disorders (Rutter & Brown, 2017).”
BackgroundHuang, Y., Zhou, Y., Wei, Y., Zeng, L., Yang, J., Li, Y., Song, X., Li, H., He, H., Li, T., et al. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s300719 · Cited by 15
The psychological impact of Behçet's disease
Hasbani, G. E., Uthman, I. W., Jawad, S., & Jawad, A. S. M. (2022) · Musculoskeletal Care · doi:10.1002/msc.1632 · Cited by 15
Noij, L. C. E., Haarman, E. G., Hashimoto, S., Terheggen‐Lagro, S. W. J., Altenburg, J., Twisk, J. W. R., & Verkleij, M. (2023) · Pediatric Pulmonology · doi:10.1002/ppul.26427 · Cited by 14
Fuming, Z., Weihui, X., Jiajia, Y., Shufeng, L., Yiyi, Z., Wenjian, L., Yan, L., Zhicheng, L., Siyun, Z., Yingmin, Z., et al. (2022) · Trials · doi:10.1186/s13063-022-06258-0 · Cited by 9
“Anxiety and depression symptoms Anxiety will be measured with the 7-item Generalized Anxiety Disorder Scale (GAD-7; range, 0–21; higher scores indicate greater severity) [25].”
MethodPereira, A. P. D., Janela, D., Areias, A. C., Molinos, M., Tong, X., Bento, V., Yanamadala, V., Atherton, J., Correia, F. D., & Costa, F. M. T. A. (2025) · JMIR mhealth and uhealth · doi:10.2196/68242 · Cited by 15
“MCIC: ≥3.8 [50] Outcome and measure Description WPAI c • WPAI questionnaire–General Health v2.”
InfluentialHicks, M. D., Braden, L., Walsh, E. M., Greene, B., & Grayson, J. W. (2021) · The Journal of Laryngology & Otology · doi:10.1017/s0022215121003091 · Cited by 13
Flourishing in head and neck cancer survivors
Harris, A. L., Li, J., Atchison, K., Harrison, C. A., Hall, D. E., VanderWeele, T. J., Johnson, J. T., & Nilsen, M. L. (2022) · Cancer Medicine · doi:10.1002/cam4.4636 · Cited by 12
Jiao, C.-Y., Song, X., Shao, W.-Y., Feng, L.-P., & Jiao, D. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.1015331 · Cited by 13
“org Generalized anxiety scale The scale was based on the quantitative evaluation criteria recommended by the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), published by the American Psychological Association (Toussaint et al., 2020).”
MethodVerkleij, M., Georgiopoulos, A. M., Barendrecht, H., & Friedman, D. (2023) · Pediatric Pulmonology · doi:10.1002/ppul.26438 · Cited by 13
“An MID of four points has been established.(35)”
BackgroundUchida, H., Kuroiwa, C., Ohki, S., Takahashi, K., Tsuchiya, K., Kikuchi, S., & Hirao, K. (2023) · Psychology Research and Behavior Management · doi:10.2147/prbm.s417446 · Cited by 14
“However, considering patient burden and the busy clinical situation, PROs must be simple for the respondent, scorer, or interpreter.(30) Therefore, there is an urgent need to develop PROs that can identify early-stage psychological distress and can assess changes in disease severity among patients receiving treatment…”
BackgroundJi, Y., Chen, H., Yang, Y., Zhou, Y., Li, H., Jin, H., Xie, J., & Shen, B. (2023) · Cancer Medicine · doi:10.1002/cam4.6577 · Cited by 11
Wirkner, J., & Brakemeier, E. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1283919 · Cited by 17
Vitorino, L. M., Sousa, L., Trzesniak, C. M. F., VALENTİM, O. M. M. D. S., Júnior, G. H. Y., JOSÉ, H. M. G., & Lucchetti, G. (2021) · Quality of Life Research · doi:10.1007/s11136-021-03031-9 · Cited by 13
Tsirmpas, C., Nikolakopoulou, M., Kaplow, S., Andrikopoulos, D., Fatouros, P., Kontoangelos, K., & Papageorgiou, C. (2023) · JMIR Formative Research · doi:10.2196/48362 · Cited by 11
“Minimal clinically important differences were defined as at least 5 points for the PHQ-9 scores [51] and at least 4 points for the GAD-7 scores [52].”
Internet-based self-help intervention for procrastination: randomized control group trial protocol
Ying, Z., & Wang, J. (2023) · Trials · doi:10.1186/s13063-023-07112-7 · Cited by 20
Mordeno, I. G., Luzano, J. G. C., Gallemit, I. M. J. S., & Gonzaga, E. Z. J. (2023) · Psychology in the Schools · doi:10.1002/pits.22939 · Cited by 15
Demirbas, M., Hahn‐Pedersen, J. H., & Jørgensen, H. L. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00493-6 · Cited by 13
“8 and is based on individuals with comorbid depression and anxiety symptoms [17, 18].”
BackgroundTsang, V. W. L., Ragazan, D. C., Kryskow, P., Walsh, Z., & Dames, S. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2253798 · Cited by 14
“Our observed reductions satisfy proposed benchmarks for establishing clinically substantial improvements in symptoms and functioning as assessed by the PHQ-9 (∆ ≥ 6 points; Turkoz et al. 2021), GAD-7 (∆ ≥ 4 points; Toussaint et al. 2020), and PCL-5 (∆ ≥ 15 points; Marx et al. 2022).”
Kalde, J., Atik, E., Stricker, J., Schückes, M., Neudeck, P., Pittig, A., & Pietrowsky, R. (2023) · Psychotherapy Research · doi:10.1080/10503307.2023.2277866 · Cited by 14
“A recent study related to our work demonstrated the sensitivity of the GAD-7 for detecting symptom improvement in patients with depression over 12 weeks (Toussaint et al., 2020).”
Ketel, J., Bruguera, M. B., Auchter, G., Cuntz, U., Zipfel, S., Enck, P., & Mack, I. (2024) · Nutrients · doi:10.3390/nu16060891 · Cited by 12
“Therefore, an improvement of four points in depression or anxiety symptom severity scores was set as MCID [57].”
BackgroundCao, X., Dong, Y., Yu, H., Liu, X., Gu, Y., Song, J., Ouyang, P., & Hong, Z. (2024) · Heart & Lung · doi:10.1016/j.hrtlng.2024.04.003 · Cited by 12
Liu, C., Xu, Y., Sun, H., Yuan, Y., Lu, J., Jiang, J., & Liu, N. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05932-8 · Cited by 14
“The General Anxiety Disorder 7 (GAD-7) was used to assess participants’ AS over the previous 2 weeks [39].”
MethodNguyen, M., MacDiarmid, P., Tanzler, A., Dagenais, R., Bevanda, C., & Quon, B. S. (2024) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2024.07.008 · Cited by 12
Wu, M. S., Wickham, R. E., Chen, S.-Y., Varra, A. A., Chen, C., & Lungu, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313112 · Cited by 13
Relevant factors contributing to risk of suicide among adolescents
Cheng, L., Song, W., Zhao, Y., Zhang, H., Wang, J., Lin, J., & Chen, J. (2025) · BMC Psychiatry · doi:10.1186/s12888-024-06421-8 · Cited by 15
“The internal consistency of the scale was good; Cronbach’s α coefficient was 0.92 [13, 14].”
InfluentialThe mental health of Chinese healthcare staff in non-epicenter of COVID-19: a cross-sectional study
Zhang, L., Wang, S., Shen, J., Wang, Y., Huang, X., Wu, F. Q., Zheng, X., Zeng, P., & Qiu, D. (2020) · Annals of Palliative Medicine · doi:10.21037/apm-20-2041 · Cited by 12
“The response options include ‘not at all’, ‘on some days’, ‘on more than half of the days’, and ‘almost every day’ (scored 0–3, with a total score ranging from 0 to 21) (18).”
Þórarinsdóttir, K., Holmes, E. A., Hardarson, J., Héðinsdóttir, U., Kanstrup, M., Singh, L., Hauksdóttir, A., Halldorsdottir, T., Guðmundsdóttir, B., Valdimarsdóttir, U. A., et al. (2021) · JMIR Formative Research · doi:10.2196/29873 · Cited by 11
Salles, J. I., Silva, C., Wolff, A., Orwert, L., Ribeiro, P. F. M., Velasques, B., & Morrissey, D. (2022) · Psicologia Reflexão e Crítica · doi:10.1186/s41155-022-00233-z · Cited by 12
Xia, C., Zheng, H., Zhang, S., Tang, L., Jing, Q., Chen, G., Sun, M., & Lü, J. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.101 · Cited by 12
Wright, A. A., Poort, H., Tavormina, A., Schmiege, S. J., Matulonis, U. A., Campos, S. M., Liu, J. F., Slivjak, E. T., Gilmour, A. L., Salinger, J. M., et al. (2023) · Gynecologic Oncology · doi:10.1016/j.ygyno.2023.08.020 · Cited by 12
Cai, L., Tao, Q., Li, W., Zhu, X., & Cui, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.971853 · Cited by 11
Solomon, J. J., Hallowell, R. W., Ganslandt, C., Shull, J. G., Bengtsson, T., Ganslandt, J., & Horton, M. R. (2024) · Respirology · doi:10.1111/resp.14859 · Cited by 11
“13 Indeed, 75% of participants with a score corresponding to moderate anxiety at baseline in the current study shifted to mild (25”
Han, A., Oster, R. A., Yuen, H. K., Jenkins, J., Hawkins, J., & Edwards, L. (2025) · JMIR Formative Research · doi:10.2196/67545 · Cited by 15
“These changes exceed the estimated MCID on the GAD-7 [39,40].”
Uswatte, G., Taub, E., Ball, K., Mitchell, B. S., Blake, J. A., McKay, S., Biney, F., Iosipchuk, O., Hempfling, P., Harris, E., et al. (2025) · Rehabilitation Psychology · doi:10.1037/rep0000626 · Cited by 11
Powell, S. K., Saali, A., Frere, J. J., Magill, E. B., Krystal, H. L., Serafini, R. A., Sultana, S., Dale, B., Ali, M. O., Kumar, V., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04112-w · Cited by 11
“To do so, we employed the current consensus definition of a “clinically significant improvement” (CSI) as a reduction in symptom severity of 50% or more [26, 27].”
MethodAnxiety and Depression Detection using Machine Learning
Aggarwal, R., & Goyal, A. (2022) · International Conference on Machine Learning, Big Data, Cloud and Parallel Computing (COM-IT-CON) · doi:10.1109/com-it-con54601.2022.9850532 · Cited by 14
Murea, M., Highland, B. R., Yang, W. Z., Dressler, E. V. M., & Russell, G. B. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02946-w · Cited by 11
“Prior work suggested a minimum change in DSI score of 7 points [40], in GAD-7 score of 4 points [41], and in PHQ-9 score of 5 points [42] as the cut-offs for minimal important change.”
Desai, M. Z. J. H., Khan, A. R., Kulkarni, R., & Hegde, B. (2020) · Journal of Ideas in Health · doi:10.47108/jidhealth.vol3.issspecial1.51 · Cited by 11
“The total score ranges from 0 to 21, indicating the severity of anxiety in three levels (mild/moderate/severe) depending on the score [15].”
BackgroundMinhas, M., Belisario, K. L., González‐Roz, A., Halladay, J. E., Morris, V. L., Keough, M. T., Murphy, J. G., & MacKillop, J. M. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14724 · Cited by 11
Jeanbert, E., Baumann, C., Todorović, A., Tarquinio, C., Rousseau, H., & Bourion-Bédès, S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192114359 · Cited by 11
Digital mental health interventions as stand-alone vs. augmented treatment as usual
Nelson, B. W., Peiper, N. C., & Forman‐Hoffman, V. L. (2024) · BMC Public Health · doi:10.1186/s12889-024-18412-1 · Cited by 10
“Important Difference (MCID) refers to smallest change in scores that are of “perceived benefit” to the patient and was defined as a PHQ-9 score reduction of ≥ 5 [21] and a GAD-7 score reduction of ≥ 4 [22] for patients with a 5 or above starting PHQ-9 and GAD-7 score, respectively.”
BackgroundGonzález-Domínguez, N. P., Wu, Y., Fan, S., Levis, B., Sun, Y., Gilbody, S. M., Ioannidis, J. P. A., Harel, D., Vigod, S. N., Markham, S., et al. (2024) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2024.111443 · Cited by 13
Luo, X., Liu, W., Sun, N., Bo, P., Chen, Y., Han, Q., Li, N., Lu, X.-Z., Jianjun, M., Sun, G., et al. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14870 · Cited by 10
Meng, P., Pan, C., Qin, X., Cai, Q., Zhao, Y., Wei, W., Cheng, S., Yang, X., Cheng, B., Liu, L., et al. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117121 · Cited by 11
Gao, R., Wang, H., Liu, S., Wang, X., Song, S., & Wang, Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1385639 · Cited by 10
Zhu, Y., Chen, Y., Tang, Y., Zhang, X., Shen, Q., Li, F., Wang, H., & Zheng, X. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1483021 · Cited by 10
Pacut, A., Duplaga, M., Więcek, S., Murzyn, I., Gronowicz, G., Krzesiek, E., Stalony, N., & Kowalska‐Duplaga, K. (2025) · BMC Public Health · doi:10.1186/s12889-025-24329-0 · Cited by 14
Czenczek‐Lewandowska, E., Leszczak, J., Wyszyńska, J., Baran, J., Weres, A., & Lewandowski, B. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191711086 · Cited by 12
Wang, C., Huan, N., Wang, P.-L., Geng, Q., Ma, W., Ma, L., Jiang, H.-Y., Meng, X., Zhang, D., Gou, X.-J., et al. (2022) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-022-3688-3 · Cited by 10
“The PHQ-9((16)) and GAD-7((17)) scoring criteria were based on the quantitative evaluation criteria recommended in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) issued by the American Psychiatric Association.”
MethodSteel, C., Wright, K. A., Goodwin, G. M., Simon, J., Morant, N. J., Taylor, R. S., Brown, M. C., Jennings, S., Hales, S. A., Regan, J. L., et al. (2023) · International Journal of Bipolar Disorders · doi:10.1186/s40345-023-00305-8 · Cited by 11
Yin, L., Rong, T., Zhang, Y., & Gao, J. (2023) · Geriatric Nursing · doi:10.1016/j.gerinurse.2023.10.005 · Cited by 10
Ittiphakorn, P., Erridge, S., Holvey, C., Coomber, R., Rucker, J., & Sodergren, M. H. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12400 · Cited by 9
“60 The Single-Item Sleep Quality Scale (SQS) is a scale used to evaluate self-reported sleep quality over the previous 7 days, with 0 being “terrible” sleep quality and 10 being “excellent”.”
MethodRoos, L. G., Henson, S. J. S., Castro, C. M., Chamberlain, C. E. W., & Smith, B. J. (2024) · JMIR mhealth and uhealth · doi:10.2196/48298 · Cited by 10
“The clinical cutoff score for probable anxiety disorder (“high risk”) is ≥ 8 [20], and improvement was indicated when participants’ scores decreased by >4 points [21].”
BackgroundElezi, F., Tafani, G., Sotiri, E., Agaj, H., & Kola, K. (2020) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_842_20 · Cited by 10
“The GAD-7 has been previously applied in research related to MERS[4] and Ebola outbreak,[10] in recent studies in China,[5] and it has been approved to be a well-valuated screening instrument.[11,12] In this study, it has demonstrated excellent internal consistency (Cronbach’s α = 0.”
MethodThe challenge of addressing obesity in people with poorly controlled asthma
Dixon, A. E., Blake, K., DiMango, E., Dransfield, M. T., Feemster, L. C., Johnson, O., Roy, G., Hazucha, H., Harvey, J. R., McCormack, M. C., et al. (2021) · Obesity Science & Practice · doi:10.1002/osp4.533 · Cited by 10
“The score changed minimally over the two study visits (median score of 2 [IQR 0–4] and 1 [IQR 0–3] at baseline and follow‐up), which is less than the minimal clinically important difference of 4.(26)”
BackgroundRoyal, S., Keeling, S., Kelsall, N., Price, L. R., Fordham, R. J., Xydopoulos, G., Dawson, G. R., Kingslake, J., & Morriss, R. K. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01681-3 · Cited by 10
“Change in thresholds for a minimally important change (improvement or deterioration) of 4 points or more on the GAD-7 [23] and 6 points or more on the PHQ-9 [24] from baseline to 8 weeks are reported descriptively.”
MethodBarone, M., Imaz, F., Bordachar, D., Ferreira, I. C., & Intelangelo, L. (2021) · Physiotherapy Theory and Practice · doi:10.1080/09593985.2021.1878567 · Cited by 9
“- 66–1.02 kgf/cm2) (Mutlu and Ozdincler, 2015; Waller et al., 2015).”
InfluentialPolfer, E. M., Alici, Y., Baser, R. E., Healey, J. H., & Bartelstein, M. K. (2022) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000002295 · Cited by 10
Li, A. Y., Erridge, S., Holvey, C., Coomber, R., Barros, D. A. R., Bhoskar, U., Crews, M., Donnelly, L., Imran, M., Korb, L., et al. (2024) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000536 · Cited by 10
“A minimal clinically important difference (MCID) is determined as a reduction of 4 points or more (Toussaint et al ., 2020).”
BackgroundTang, S. J., Holle, J., Mor, S., Dadario, N. B., Ryan, M., Teo, C., Sughrue, M. E., & Yeung, J. T. (2024) · Brain and Behavior · doi:10.1002/brb3.70088 · Cited by 9
“The minimal clinically important difference (MCID) in GAD-7 is four points (Toussaint et al. 2020).”
BackgroundZainal, N. H., Benjet, C. L., Albor, Y., Núñez-Delgado, M. J., Cruz, R. Z., Contreras‐Ibáñez, C. C., Cudris–Torres, L., de la Peña, F. R., González, N., Guerrero-López, B., et al. (2025) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.70005 · Cited by 9
Grapp, M., Bugaj, T. J., Terhoeven, V., Friederich, H., & Maatouk, I. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316853 · Cited by 9
Analysis of risk factors for depression and anxiety in women with polycystic ovary syndrome
Yang, Y., Liu, L., Hu, N., Huo, H., Yang, X., & Wang, F. (2025) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2025.1520641 · Cited by 15
Zhang, Z., Liu, Z., Lin, Y., Guo, M., Xu, X., & Peng, L. H. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1635406 · Cited by 13
Students' Anxiety during the COVID-19 Pandemic in Saudi Arabia
AL-Shahrani, A. M. (2021) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_46_21 · Cited by 9
“It analyses the 7-core symptoms and examines the frequency of these symptoms within the last two weeks.[15] The GAD-7 questionnaire was modified to test GAD and assess its severity in clinical study and practice.”
MethodWestwell-Roper, C. Y., To, S., Soller, L., Chan, E. S., & Stewart, S. E. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.04.012 · Cited by 9
“Survey components included demographic information, allergy history, and the General Anxiety Disorder—7, a measure of generalized anxiety symptoms.(8) Furthermore, current and pre−COVID-19 aspects of FAA were queried using a 28item questionnaire undergoing validation, the Impairment Measure for Parental food Allergy-r…”
Shi, Q., Ding, J., Su, H., Du, Y., Pan, T., & Zhong, X. (2023) · Psychology Research and Behavior Management · doi:10.2147/prbm.s441058 · Cited by 10
Psychological effect of COVID-19 pandemic on university students in Turkey
(2020) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.20358 · Cited by 9
“The General Anxiety Disorder Scale (GAD7), which is one of the most commonly used tools for detecting and screening anxiety disorders and developed to assist in the diagnostic process of certain diseases, is the first self-reported questionnaire [14].”
MethodZhang, D., Luo, H., Xiao, L., Zhang, Z., Huang, J., Li, X., Zhu, H., & Lai, C. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.897896 · Cited by 10
Bauer, K., Schild, S., Sauer, H., Teufel, M., Stengel, A., Giel, K. E., Schellhorn, P., Junne, F., Niess, A. M., Zipfel, S., et al. (2021) · Obesity Facts · doi:10.1159/000517850 · Cited by 11
Westas, M., Mourad, G., Andersson, G., Lundgren, J., & Johansson, P. (2024) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvad097 · Cited by 8
Lee, J. L., Billovits, C., Chen, S.-Y., Wickham, R. E., Kocher, B., Chen, C. E., & Lungu, A. (2025) · Value in Health · doi:10.1016/j.jval.2025.06.002 · Cited by 8
SFF-DA: Spatiotemporal Feature Fusion for Nonintrusively Detecting Anxiety
Mo, H., Li, Y., Han, P., Liao, X., Zhang, W., & Ding, S. (2023) · IEEE Transactions on Instrumentation and Measurement · doi:10.1109/tim.2023.3341132 · Cited by 8
“1) Traditional Anxiety Detection Methods: Psychological scales, such as the self-rating anxiety scale (SAS) [25] and generalized anxiety disorder-7 (GAD-7) item scale [26], are commonly used in conventional mental health assessments to determine whether patients are experiencing anxiety.”
BackgroundGao, R., Wang, H., Liu, S., Wang, X., Xiong, X., Song, S., & Wang, Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1387247 · Cited by 8
Chermahini, M. B., Eadie, J., Agarwal, A., Stephenson, C., Malakouti, N., Nikjoo, N., Jagayat, J., Jarabana, V., Shirazi, A., Kumar, A., et al. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241261933 · Cited by 7
Duncan, Z., Kippen, R. J., Sutton, K., Ward, B., Rathnayake, K., Quinn, B., & Dietze, P. (2024) · Addiction · doi:10.1111/add.16714 · Cited by 9
Schriger, S. H., Nurse, C. N., & O’Hayer, C. V. (2025) · Journal of Huntington s Disease · doi:10.1177/18796397251315162 · Cited by 9
“With regard to clinical signi fi cance of these changes, the minimum clinically important difference (MCID) for the PHQ-9 and GAD-7 are estimated to be 3.7 and 4.0, respectively 88,89 ; there is no established MCID for the HDQoL or CFQ-13, which limit our ability to fully interpret these changes.”
InfluentialLiu, F., Qiao, W., Han, W., Fan, X., Chen, Y., Lu, R., Zhai, Y., Pan, T., Yuan, X., Song, X., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06637-2 · Cited by 8
“Additionally, it has been noted to be sensitive in detecting changes in psychopathology over the course of treatment [37].”
Menezes, H. J., Grace, S. L., Ramachandran, P., Babu, A. S., Rao, R. R., Kamath, A., & Sonia, R. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf147 · Cited by 8
Mehta, U., Wilt, G. E., Roscoe, C., Okereke, O. I., Coull, B. A., James, P., Laden, F., Iyer, H. S., Yanosky, J. D., Kaufman, J. D., et al. (2025) · Environmental Health Perspectives · doi:10.1289/ehp14458 · Cited by 11
Mental Health in College Students before, during, and after the COVID-19 Pandemic
Dolbier, C. L., Simon, A., Dietrich, K. M., & Signorelli, J. (2025) · Emerging Adulthood · doi:10.1177/21676968251354995 · Cited by 8
“…that may have contributed to our measures ’ relative stability overtime, it is important to remain mindful that screeners such as the GAD-7 and PHQ-8 or PHQ-9 are often utilized as outcome measures in clinical settings, to track treatment progress (Shin et al., 2019; Toussaint et al., 2020).”
O’Callaghan, E., Sullivan, S., Gupta, C., Belanger, H. G., & Winsberg, M. E. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04113-9 · Cited by 9
Wu, X.-D., Chen, T., Wang, K., Wei, X., Feng, J., & Zhou, J. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-067082 · Cited by 10
Xiao, W.-X., Li, S.-Q., Xu, H., Zhang, Y., Wei, R., Tao, F., & Wan, Y. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103621 · Cited by 8
Wang, H., Zhang, D., Wang, S., Wang, H., & Nie, H. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1425796 · Cited by 8
Marițescu, A., Crișan, A. F., Pescaru, C. C., Stoicescu, E. R., Oancea, C. I., & Iacob, D. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206237 · Cited by 11
Wang, J., Yang, P., zheng, H., xu, W., Xue, W., Kan, Y., Qu, S., & Lin, F. (2024) · Journal of Pain Research · doi:10.2147/jpr.s497061 · Cited by 9
Shi, J., Chi, Y., Wang, X., Zhang, Y., Tian, L., Chen, Y., Chen, C., Dong, Y., Sang, H., Chen, M., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.845357 · Cited by 8
Metadata
- Authors
- Toussaint, A., Hüsing, P., Gumz, A., Wingenfeld, K., Härter, M., Schramm, E., & Löwe, B.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Charité – Universitätsmedizin Berlin (DE)
- University of Freiburg (DE)
- Corresponding author
- Toussaint, Anne
- ORCID
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 265
- Pages
- 395-401
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W3000661394
- Cited by
- 641
- References
- 68
- Citations by year
- 2026: 134 · 2025: 138 · 2024: 113 · 2023: 99 · 2022: 68 · 2021: 59 · 2020: 30
- FWCI
- 61.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Affective Disorders (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
- Keywords
- GAD-7, Generalized Anxiety Disorder Scale, anxiety symptoms, chronic depression, sensitivity to change, minimal clinically important difference, standardized response mean, treatment response monitoring, Hamilton Depression Rating Scale
- MeSH terms
- Minimal Clinically Important Difference, Patient Health Questionnaire, Anxiety Disorders, Depression, Humans, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review